FORMULATION AND IN-VITRO EVALUATION OF TERBUTALINE SULPHATE SUSTAINED RELEASE TABLETS

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 5

Abstract

Sustain release formulation maintain a constant level plasma concentration of drug so that multiple and night dosing can be avoided. Terbutaline sulphate is a β2 stimulant drug which is having a very short half life of less than 4 hours. It is available in conventional dosage form in thrice a day formulation. Being half life less there is always a need for dosing frequency. Decreasing dosing frequency will increase the patient compliance for asthmatic patients and thus avoiding dosing at odd hours. Terbutaline sulphate is available in market in different immediate release dosage forms. After some time plasma concentration level decreases below MEC. So the necessity of producing the drug in sustained release formulation. So an attempt is made to formulate terbutaline sulphate in sustained release formulation with different concentrations of HPMC K15 and HPMC K4M polymers so that it can provide effective drug release up to 12 hours. The powder blend is subjected to pre compressional parameters. The prepared tablets were subjected to post compressional parameters. The results of the present study showed that the polymer ratio used in the formulation F5 showed enhanced result and released the drug up to 12 hours with 99 % drug release.

Authors and Affiliations

Rajeswari Kola, Deepa Ramani N, Pragati Kumar B

Keywords

Related Articles

Calotropis gigantea (L.) Dryand – A review update

Calotropis gigantea (L.) Dryand (Giant milk weed; family Asclepiadaceae) has been traditionally used in the treatment of bronchitis, asthma, leprosy, eczema and elephantiasis. This review emphasizes on ethnopharmacolog...

Fabrication and evaluation of oro-gel containing ferrous fumarate

The present study aimed to develop Ferrous Fumarate oral jellies for the treatment of iron deficiency anemia. These jellies were prepared by using Carbapol 940 or tragacanth with different concentrations as a gelling a...

Evaluation and comparison of efficacy and safety of atorvastatin alone and in combination with Fenofibrate in dyslipidemia

The study was conducted to evaluate and compare the efficacy and safety of Atorvastatin alone and in combination with Fenofibrate in dyslipidemic patients at General Hospital, Nunna. Safety of Atorvastatin alone and in...

EVALUATION OF ANTIDIABETIC ACTIVITY OF METHANOLIC EXTRACT OF FLOWERS OF CASSIA SIAMEA IN ALLOXAN INDUCED DIABETIC RATS OF BASAL DIET AND MAIDA MIXED DIET

This study was carried out to evaluate the antihyperglycemic effect of the Methanol extracts of the flowers of C. siamea on alloxan induced rats of normal diet and maida mixed diet. The extracts were orally administered...

Formulation and characterization of Methotrexate loaded sodium alginate chitosan Nanoparticles

The aim of the present work was to formulate nanoparticles for Methotrexate drug. Methotrexate is an anticancer, disease modifying anti rheumatic drug, and BCS Class – III drug having high solubility and low permeabili...

Download PDF file
  • EP ID EP33137
  • DOI -
  • Views 267
  • Downloads 0

How To Cite

Rajeswari Kola, Deepa Ramani N, Pragati Kumar B (2013). FORMULATION AND IN-VITRO EVALUATION OF TERBUTALINE SULPHATE SUSTAINED RELEASE TABLETS. Indian Journal of Research in Pharmacy and Biotechnology, 1(5), -. https://europub.co.uk/articles/-A-33137